Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Phenytoin sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phenytoin sodium and what is the scope of phenytoin sodium patent protection?

Phenytoin sodium
is the generic ingredient in seven branded drugs marketed by Warner Chilcott, Marsam Pharms Llc, Fresenius Kabi Usa, Watson Labs, West-ward Pharms Int, Aurobindo Pharma Ltd, Smith And Nephew, Solopak, Sun Pharm Inds (in), Hospira, Sun Pharm Inds, Wockhardt Usa, Ani Pharms Inc, Pharmeral, Parke-davis, Parke Davis, Lannett, Wockhardt, Amneal Pharms Ny, X-gen Pharms, Luitpold, Taro, and Mylan, and is included in thirty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for phenytoin sodium. Forty-two suppliers are listed for this compound.

Summary for Generic Name: phenytoin sodium

Drug Master File Entries: see list19
Suppliers / Packagers: see list42
Bulk Api Vendors: see list173
Clinical Trials: see list953
Patent Applications: see list5,935
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phenytoin sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smith And Nephew
phenytoin sodium
INJECTABLE;INJECTION088521-001Dec 18, 1984DISCNNoNo► Subscribe► Subscribe
Watson Labs
phenytoin sodium
INJECTABLE;INJECTION085434-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
phenytoin sodium
CAPSULE;ORAL040298-003Dec 6, 2001ABRXNoYes► Subscribe► Subscribe
Aurobindo Pharma Ltd
phenytoin sodium
CAPSULE;ORAL204309-001Jun 10, 2015ABRXNoNo► Subscribe► Subscribe
phenytoin sodium
CAPSULE;ORAL084349-002Approved Prior to Jan 1, 1982ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus